Franck Amblard

This study evaluates DFMA's antiviral efficacy against multiple coronaviruses in vitro and in vivo, showing significant reductions in viral load and inflammation across different models.

This paper identifies the mechanism of resistance to the HIV-1 integrase inhibitor pirmitegravir and develops a more potent analog to overcome this resistance.

This paper develops AORBs, a high-throughput human airway organoid system, to robustly assess antiviral efficacy against SARS-CoV-2 with high throughput and clinical relevance.